Fundraising Fox

PsyMed Ventures

Venture capitalActively deploying

Berkeley · Pre-Seed–Series A · 12 people tracked

Also known as PSYMED VENTURES MANAGEMENT LLC

Fox Verdict
Sign up to see your fit

Investment thesis

PsyMed Ventures backs founders working to transform the mental and brain illness epidemic through frontier science and technology. Its focus spans neurotech and human augmentation, brain-computer interfaces, precision neuroscience, artificial intelligence for early detection and diagnosis, new therapeutic modalities (genetic, RNA, cell-based), holistic and neurometabolic approaches, platforms and novel compounds, and digital health and therapeutics. The firm seeks companies that align healing, responsibility, and profitability, aiming to shift care from generalized to individualized while addressing root causes of mental and neurological disease.

Source: firm website, verified Aug 7, 2026.

Stage
Pre-Seed–Series A
HQ
Berkeley, California, US
Instruments
Equity
Founded
2020
AUM
$25M
VC funds
2
Tracked investments
28

Team · 12 people

from the firm's website & public directories

What they invest in

from 14 of 28 portfolio companies

Biotech ×11Digital Health ×9Healthtech ×6Mental Health ×5AI & Machine Learning ×4Medical Devices ×4Deep Tech ×2AgTech ×1

HQs:United States×4

Investments · 28 tracked

founders shown can be your intro path
Aerskaaerska.comin

Aerska develops RNA interference (RNAi) medicines designed for targeted delivery across the blood-brain barrier to treat, delay, and prevent central nervous system and neurological diseases.

BiotechDeep TechMedical Devices

Stuart Milstein(Co-Founder)Jack O’Meara

Ancilia Bioanciliabio.comin

Ancilia uses CRISPR technology to engineer bacterial products with resistance to destructive viruses, enabling their use as live biotherapeutics.

Biotech

Bexson Biomedicalbexsonbiomedical.com
Bloom Sciencebloomscience.com
bright-mindsbrightmindsbio.com
Delixdelixtherapeutics.comin

Delix develops neuroplastogen-based therapeutics to treat neuropsychiatric conditions by promoting neuroplasticity and rewiring neural circuits.

BiotechDigital HealthMedical Devices

Freedom Biosciencesfreedombio.coin𝕏

Freedom Biosciences develops neuropsychiatric therapeutics, focusing on novel treatments for conditions including depression, PTSD, and alcoholism.

BiotechDigital HealthMental Health

Dr. John Krystal(Co-founder & CEO)Dina Burkitbayeva(Co-founder)

Gilgamesh Pharmaceuticalsgilgameshpharmaceutical.comin𝕏

Gilgamesh Pharmaceutical develops novel chemical entities for psychiatric disorders using medicinal chemistry and AI-powered translational platforms to design rapid-acting therapies targeting neurobiological mechanisms rather than symptom management.

AI & Machine LearningBiotechDigital HealthHealthtechNew York City, US

Jonathan Sporn(Founder)inAndrew Kruegel(Founder)inDalibor Sames(Founder)inJONATHAN SPORN(Founder)inThomas Kevin Murphy, Ph.D.(Executive Officer)Andrew Kruegel, Ph.D.(Executive Officer)

Humans Anonymoushumansanon.com
Imyooimyoo.healthin𝕏

ImYoo is a Public Benefit Corporation that provides at-home immune sample collection kits and molecular profiling to map patients' experiences to their underlying biology.

BiotechDigital HealthHealthtech

IRIS MEDICINEirismedicine.com
Jimini Healthjiminihealth.com
Journey Clinicaljourneyclinical.comin𝕏

Journey Clinical provides ketamine-assisted psychotherapy (KAP) for depression, anxiety, and PTSD, partnering patients with licensed therapists and medical teams while coordinating with major insurance providers.

Digital HealthMedical DevicesMental Health

mayamayahealth.com

Maya Health (Naitur) builds compliance-focused AI automation for independent health and wellness practices, covering intake-to-EMR sync, follow-ups, lab result delivery, rating-scale scoring, and safety escalation.

AI & Machine LearningDigital HealthHealthtech

Mindstate Design Labsmindstate.designin𝕏

Mindstate Design Labs is a clinical-stage drug development company that uses AI to map the biological basis of emotion and cognition, synthesizing psychedelic phenomenology and biochemical data to design pharmaceutical compounds that induce specific therapeutic emotional and cognitive states for mental health treatment.

AI & Machine LearningBiotechHealthtechMental HealthSan Francisco, US

Dillan DiNardo(Founder/CEO)inTom Ray(Founder)in

BoardRand Hindi(Director)in

Motif Neurotechmotifneuro.techin𝕏

Motif Neuro develops neural devices to monitor and regulate mental health and performance, with an initial focus on treatment-resistant depression using bioelectronic implants called DOT that are deployed via outpatient procedure.

BiotechDigital HealthHealthtechMedical DevicesHouston, US

Anthony Arnold(Director)Jacob Robinson(Executive Officer, Director)Thomas M. Shehab(Director)Amy Kruse(Director)

NEURODEneurodelabs.com𝕏
PODCASTbusinesstrip.fm
Remepyremepy.comin

Remepy develops "Hybrid Drugs" that combine pharmaceuticals with targeted digital interventions to deliver personalized and adaptive therapies for patients.

AI & Machine LearningBiotechDigital Health

Resetpharmaresetpharma.comin𝕏

Reset Pharma is a neuro-biotechnology company developing first-in-class, psilocybin-inspired therapies aimed at treating demoralization syndrome and psychological trauma in people facing life-altering diseases such as cancer.

BiotechDigital HealthMental Health

Sanmai

Transcranial focused ultrasound for mental health

Stealth Biotech

Precision biologics for neuroinflammation

Stealth Healthcare

Integrated solution for cancer-specific behavioral health

Stealth Marketplace

Marketplace for transformational mental health modalities

Stealth Neurotech
Tactogentactogen.comin𝕏

Tactogen develops patented new chemical entities, including benzofuran-based compositions, and conducts preclinical research and publishes data on these compounds.

BiotechDeep TechHealthtech

Matthew Baggott(CEO)

Terranterranbiosciences.com
Tripptripp.comin𝕏

TRIPP provides immersive meditation and mindfulness experiences available through a mobile app and VR headset platform.

AgTechMental HealthWellness & FitnessVenice, US

Tim Chang(Director)Nanea Reeves(Executive Officer, Director)Zachary Norman(Executive Officer, Director)Kevin Keeland(Executive Officer)

Frequently asked questions

What stage does PsyMed Ventures invest at?
PsyMed Ventures invests at the Pre-Seed, Seed, Series A stages.
What sectors does PsyMed Ventures focus on?
PsyMed Ventures focuses on AI & Machine Learning, Biotech, Deep Tech, Digital Health, Healthtech, Longevity, Medical Devices, Mental Health, Wellness & Fitness.
Where is PsyMed Ventures located?
PsyMed Ventures is headquartered in Berkeley, US.

Media · Podcasts & interviews

featuring the team

Investing In The Next Frontiers of Mental Health (Greg Kubin, PsyMed Ventures)

Scott Britton · Greg Kubin

Podcast E047: Dina Burkitbayeva of PsyMed Ventures

Female VC Lab · Dina Burkitbayeva

Images

PsyMed Ventures photoPsyMed Ventures photo

Co-investors · 7

Mayfield Fund

Mayfield Fund is a venture capital firm publishing perspectives on artificial intelligence, focusing on what it calls the Collaborative Intelligence era where humans and AI work together.

Both backed · 1
$500K – $12M
RA Capital

RA Capital invests in public and private healthcare and life science companies developing pharmaceuticals, medical devices, and diagnostic tools. The firm operates as a crossover fund across multiple investment stages.

Both backed · 1
Artis Ventures

Artis Ventures is a venture capital firm focused on supporting founders reimagining the systems that sustain life, spanning from cellular biology to broader societal impact.

Both backed · 1
$50K – $25M
Baruch Future Ventures

Baruch Future Ventures is a climate-tech focused family investment firm that backs entrepreneurs building companies in the climate economy.

$100K – $1M
What If Ventures

What If Ventures is a venture capital firm investing in transformative technology, with a focus on healthcare/mental health and defense technology.

Mystic Ventures

Mystic Ventures is an early-stage investor backing teams in psychedelic medicine and consciousness expansion, focusing on companies at the intersection of biotechnology, AI, and longevity.

Firms observed investing alongside PsyMed Ventures, from public investor directories. Shared companies are the overlap with PsyMed Ventures's recorded portfolio.

Similar investors

Featured in lists